Pursuant to the Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, MPS has informed that the Company is organising a Conference Call on the acquisition of Unbound Medicine, Inc., USA by MPS North America LLC, a wholly-owned subsidiary of the Company on Wednesday, 18 February 2026, at 07:00 pm (IST). The Conference Call Invite for the above conference is enclosed. The same is also available on the Company's website at www.mpslimited.com under the head Investors.
The above information is a part of company’s filings submitted to BSE.
